Starbuck's caffeinated profits

By Yale Bock

In October, the Long Term GARP portfolio lost 1.3% versus a 1.7% retreat for the S&P 500.

The biggest event for our holdings involved the investment by Liberty Media (LMCA) to ultimately purchase the Formula One , European-dominated auto racing franchise.

Another Liberty transaction involves the split off of the Liberty Ventures' holdings in Expedia into a new stock, which will begin trading during the first week of November.

 

Starbucks Dividend

Quite a few portfolio holdings will report earnings in November, including BP Plc (BP) , IAC/InterActive (IACI) , Starbucks (SBUX) , all of the Liberty family, Intuit (INTU) , and Cie Financiere Richemont (CFRHF) .

Quest Diagnostics (DGX) exceeded consensus estimates with its earnings report in October.

I expected Starbucks would soon raise its dividend as the company has done consistently over the past few years.

Right on cue, the giant coffee chain delivered better-than-expected earnings on November 3 and unveiled a healthy dividend hike to 54 cents a share.

 

Portfolio Additions

The opportunity to invest more capital into QVC, a Liberty company, presented itself and I added to that position.

The same holds true for Richemont, in which I invested in last May.

I also initiated a small position in Rite Aid (RAD) based on the likelihood the Walgreens transaction will be approved and completed ahead of schedule.



Photo Credit: machu. via Flickr Creative Commons
Yale Bock

Yale Bock

Y H & C Investments is a registered investment adviser based in Nevada. Yale Bock founded the firm after 15

More from Stocks

Stocks Are Lower as Dow Heads for Eighth Straight Drop

Stocks Are Lower as Dow Heads for Eighth Straight Drop

Novo Nordisk Stock Pops Nearly 3% on Positive Diabetes-Drug Results

Novo Nordisk Stock Pops Nearly 3% on Positive Diabetes-Drug Results

Video: Here's Why One Markets Pro Is Raising Cash Right Now

Video: Here's Why One Markets Pro Is Raising Cash Right Now

Why Spotify Is the Ultimate Speculative Stock to Buy

Why Spotify Is the Ultimate Speculative Stock to Buy

Mesoblast Soars on Stem-Cell Treatment Data

Mesoblast Soars on Stem-Cell Treatment Data